Literature DB >> 17403134

Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia.

M Y Lipin1, V N Stepanshina, I G Shemyakin, T M Shinnick.   

Abstract

Most multidrug-resistant (MDR) Mycobacterium tuberculosis isolates in Russia belong to the Beijing or Latino-American and Mediterranean (LAM) spoligotype families. The objective of this study was to investigate possible associations between genotype and the frequencies of mutations that confer drug resistance in a population that has two large families of circulating strains. Spoligotyping, IS6110 restriction fragment length polymorphism typing, and sequencing of the katG and rpoB genes, were performed for 217 consecutive MDR M. tuberculosis isolates from patients. The rpsL and rrs genes were also sequenced for selected streptomycin-resistant isolates. Of the 217 MDR isolates, 99 (46%) belonged to the LAM family, 92 (42%) to the Beijing family, 21 (10%) to the Haarlem family and four (2%) to the T family. There was one unique spoligotype. Mutations in the katG gene were identified in 207 (95%) isolates, all of which had mutations in codon 315. Mutations in the rpoB gene were identified in 200 (92%) isolates; 75% of LAM isolates carried a mutation in codon 516, whereas 71% of Beijing isolates carried a mutation in codon 531. In the 33 isolates resistant to streptomycin 50 mg/L, the 43AGG rpsL mutation was found in 27% of Haarlem, 75% of Beijing and 0% of LAM isolates, and rrs mutations were found in 17% (516C-->T) of Beijing and 100% (513A-->C) of LAM isolates. Overall, there appeared to be a correlation between the genotype and specific mutations conferring resistance to rifampicin or streptomycin in the Beijing and LAM families. The biological implications of this correlation remain to be explored.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17403134     DOI: 10.1111/j.1469-0691.2007.01711.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  31 in total

1.  Evaluation of the AID TB resistance line probe assay for rapid detection of genetic alterations associated with drug resistance in Mycobacterium tuberculosis strains.

Authors:  C Ritter; K Lucke; F A Sirgel; R W Warren; P D van Helden; E C Böttger; G V Bloemberg
Journal:  J Clin Microbiol       Date:  2014-01-08       Impact factor: 5.948

2.  Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis.

Authors:  Lukas Fenner; Matthias Egger; Thomas Bodmer; Ekkehardt Altpeter; Marcel Zwahlen; Katia Jaton; Gaby E Pfyffer; Sonia Borrell; Olivier Dubuis; Thomas Bruderer; Hans H Siegrist; Hansjakob Furrer; Alexandra Calmy; Jan Fehr; Jesica Mazza Stalder; Béatrice Ninet; Erik C Böttger; Sebastien Gagneux
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

3.  Characterization of Mutations Conferring Resistance to Rifampin in Mycobacterium tuberculosis Clinical Strains.

Authors:  Tomasz Jagielski; Zofia Bakuła; Anna Brzostek; Alina Minias; Radosław Stachowiak; Joanna Kalita; Agnieszka Napiórkowska; Ewa Augustynowicz-Kopeć; Anna Żaczek; Edita Vasiliauskiene; Jacek Bielecki; Jarosław Dziadek
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

4.  Spoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland.

Authors:  Tomasz Jagielski; Ewa Augustynowicz-Kopec; Thierry Zozio; Nalin Rastogi; Zofia Zwolska
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

5.  Characterization of mutations conferring extensive drug resistance to Mycobacterium tuberculosis isolates in Pakistan.

Authors:  Asho Ali; Rumina Hasan; Kauser Jabeen; Nusrat Jabeen; Ejaz Qadeer; Zahra Hasan
Journal:  Antimicrob Agents Chemother       Date:  2011-09-12       Impact factor: 5.191

6.  Drug resistant Mycobacterium tuberculosis of the Beijing genotype does not spread in Sweden.

Authors:  Solomon Ghebremichael; Ramona Groenheit; Alexandra Pennhag; Tuija Koivula; Emmi Andersson; Judith Bruchfeld; Sven Hoffner; Victoria Romanus; Gunilla Källenius
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

7.  Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.

Authors:  Danica Helb; Martin Jones; Elizabeth Story; Catharina Boehme; Ellen Wallace; Ken Ho; JoAnn Kop; Michelle R Owens; Richard Rodgers; Padmapriya Banada; Hassan Safi; Robert Blakemore; N T Ngoc Lan; Edward C Jones-López; Michael Levi; Michele Burday; Irene Ayakaka; Roy D Mugerwa; Bill McMillan; Emily Winn-Deen; Lee Christel; Peter Dailey; Mark D Perkins; David H Persing; David Alland
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

8.  Impacts of dosing frequency of the combination rifampin-streptomycin on its bactericidal and sterilizing activities against Mycobacterium ulcerans in mice.

Authors:  Baohong Ji; Aurélie Chauffour; Alexandra Aubry; Jérome Robert; Murad Ibrahim; Vincent Jarlier
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

9.  Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance.

Authors:  Indra L Bergval; Anja R J Schuitema; Paul R Klatser; Richard M Anthony
Journal:  J Antimicrob Chemother       Date:  2009-07-04       Impact factor: 5.790

10.  Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America.

Authors:  Elis R Dalla Costa; Marta O Ribeiro; Márcia S N Silva; Liane S Arnold; Diana C Rostirolla; Patricia I Cafrune; Roger C Espinoza; Moises Palaci; Maria A Telles; Viviana Ritacco; Philip N Suffys; Maria L Lopes; Creuza L Campelo; Silvana S Miranda; Kristin Kremer; Pedro E Almeida da Silva; Leila de Souza Fonseca; John L Ho; Afrânio L Kritski; Maria L R Rossetti
Journal:  BMC Microbiol       Date:  2009-02-19       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.